Direct medical mental health care costs of schizophrenia in France, Germany and the United Kingdom - findings from the European Schizophrenia Cohort (EuroSC).
OBJECTIVE
To quantify and compare the resource consumption and direct costs of medical mental health care of patients suffering from schizophrenia in France, Germany and the United Kingdom.


METHODS
In the European Cohort Study of Schizophrenia, a naturalistic two-year follow-up study, patients were recruited in France (N=288), Germany (N=618), and the United Kingdom (N=302). Data about the use of services and medication were collected. Unit cost data were obtained and transformed into United States Dollar Purchasing Power Parities (USD-PPP). Mean service use and costs were estimated using between-effects regression models.


RESULTS
In the French/German/UK sample estimated means for a six-month period were respectively 5.7, 7.5 and 6.4 inpatient days, and 11.0, 1.3, and 0.7 day-clinic days. After controlling for age, sex, number of former hospitalizations and psychopathology (CGI score), mean costs were 3700/2815/3352 USD-PPP.


CONCLUSIONS
Service use and estimated costs varied considerably between countries. The greatest differences were related to day-clinic use. The use of services was not consistently higher in one country than in the others. Estimated costs did not necessarily reflect the quantity of service use, since unit costs for individual types of service varied considerably between countries.
Heider
Dirk
D
Health Economic Research Unit, Department of Psychiatry, University of Leipzig, Germany. heidd@medizin.uni-leipzig.de
Bernert
Sebastian
S
König
Hans-Helmut
HH
Matschinger
Herbert
H
Hogh
Theresa
T
Brugha
Traolach S
TS
Bebbington
Paul E
PE
Azorin
Michel
M
Angermeyer
Matthias C
MC
Toumi
Mondher
M